Pfizer's Clinical Trial Exposed in Devastating Editorial: Kids 'More Likely' to Get Severe Covid with Vaccines
"While adult Covid vaccines clearly met this standard in late 2020, the toddler vaccines don’t"...
The Wall Street Journal unleashed an editorial over Independence Day weekend that is a devastating takedown of the rush to get all toddlers jabbed with Covid vaccines and boosters.
"In fact, we don’t know if the vaccines are safe and effective," Allyssia Finley wrote in a WSJ editorial. "The rushed FDA action was based on extremely weak evidence. It’s one thing to show regulatory flexibility during an emergency. But for children, Covid isn’t an emergency. The FDA bent its standards to an unusual degree and brushed aside troubling evidence that warrants more investigation."
"While adult Covid vaccines clearly met this standard in late 2020, the toddler vaccines don’t," Finley added.
"Only 209 kids between 6 months and 4 years old have died from Covid—about 0.02% of all virus deaths in the U.S.," the editorial adds. "About half as many toddlers were hospitalized with Covid between October 2020 and September 2021 as were hospitalized with the flu during the previous winter. More children were hospitalized during the Omicron wave last winter, but hospitalization rates were still roughly in line with the 2019-20 flu season. None of the 5,400 or so toddlers in Moderna’s trial were hospitalized for Covid. Yet at least 15 were hospitalized for non-Covid infections."
The money line from the editorial should give every concerned parent pause before lining their kids up for endless Covid shots and boosters.
"More troubling, vaccinated toddlers in Pfizer’s trial were more likely to get severely ill with Covid than those who received a placebo," WSJ notes. "Pfizer claimed most severe cases weren’t 'clinically significant,' whatever that means, but this was all the more reason that the FDA should have required a longer follow-up before authorizing the vaccine."
"Also worrisome: Most kids who developed multiple infections during the trial were vaccinated," the editorial adds. "This warranted more investigation, since experimental vaccines for other diseases sometimes increase susceptibility to infection."
Dr. Marty Makary, a Johns Hopkins medical professor and Fox News Contributor, explained that healthy children's low susceptibility to Covid and natural immunity should play a key role in a doctor and parent deciding whether a given child should be inoculated.
"For kids with a special medical condition, I would say it's a good idea [to get vaccinated] if they've not had COVID in the past, but for the vast majority of healthy kids, the case may be there, but it's certainly not compelling," Dr. Marty Makary, a Johns Hopkins medical professor, told Fox News. "If you look at the fact that 75% of kids had COVID as of a CDC study back in February and Omicron has been ubiquitous since then, 80 to 90 plus percent of kids have already had COVID. So we're talking about immunizing those who are already immune for a lot of people. That just does not make sense."
Good points but amazing they still cling to the belief that they were effective in adults.
There were so many public commenters during the FDA hearing for approval who presented this worrisome information but the panel seemed more concerned with making the shots instantly available for the parents who were freaking out about their children getting Covid rather than discussing the data in order to make a solid decision. It’s criminal. Glad to see the WSJ published this.